Medpace Holdings (MEDP) IPO Opens Up 22%

August 11, 2016 10:29 AM EDT
Get Alerts MEDP Hot Sheet
Trade MEDP Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Today's IPO for Medpace Holdings (NASDAQ: MEDP) opened for trading at $28.15 after pricing 7,000,000 shares of common stock at a public offering price of $23.00 per share.

Jefferies LLC and Credit Suisse Securities (USA) LLC are acting as joint lead book-running managers for the offering. UBS Securities LLC and Wells Fargo Securities, LLC are also acting as joint book-running managers for the offering. Robert W. Baird & Co. Incorporated and William Blair & Company, L.L.C. are acting as co-managers for the offering.

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,300 people across 35 countries.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot IPOs, IPOs

Related Entities

Credit Suisse, UBS, William Blair, Jefferies & Co, Robert W Baird, Wells Fargo, IPO

Add Your Comment